PROM1 and hepatocellular carcinoma: The GLI inhibitor GANT61 demonstrates significant anti-proliferative effects on CD44+ HCC models and reverses sorafenib resistance (614), while the natural compound berberine inhibits the PARD3-mediated Shh pathway, reducing CD133+ Liver-CSC self-renewal capacity (615).